Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)
China
· Delayed Price · Currency is CNY 24.02
-0.25 (-1.03%)
At close: Mar 9, 2026
SHA:688163 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | - | 182.11 | 150.92 | 515.73 | 115.88 | Upgrade
|
| Short-Term Investments | - | 9.26 | - | - | - | Upgrade
|
| Trading Asset Securities | - | 641.21 | 722.59 | 417.62 | 65.15 | Upgrade
|
| Cash & Short-Term Investments | 786.25 | 832.58 | 873.51 | 933.35 | 181.03 | Upgrade
|
| Cash Growth | -5.56% | -4.69% | -6.41% | 415.59% | 53.10% | Upgrade
|
| Accounts Receivable | - | 36.68 | 22.63 | 7.68 | 9.59 | Upgrade
|
| Other Receivables | - | 0.86 | 0.8 | 0.98 | 6.25 | Upgrade
|
| Receivables | - | 37.54 | 23.43 | 8.66 | 15.84 | Upgrade
|
| Inventory | - | 43.28 | 44.75 | 54.53 | 49.18 | Upgrade
|
| Other Current Assets | - | 2.97 | 7.24 | 0.51 | 1.89 | Upgrade
|
| Total Current Assets | - | 916.36 | 948.93 | 997.05 | 247.93 | Upgrade
|
| Property, Plant & Equipment | - | 157.34 | 127.82 | 117.42 | 103.67 | Upgrade
|
| Long-Term Investments | - | - | 16.59 | 17.35 | 19.81 | Upgrade
|
| Other Intangible Assets | - | 23.03 | 23.79 | 24.24 | 23.97 | Upgrade
|
| Long-Term Deferred Tax Assets | - | 8 | 9.91 | 9.29 | 5.09 | Upgrade
|
| Long-Term Deferred Charges | - | 0.63 | 0.87 | 1.11 | 1.35 | Upgrade
|
| Other Long-Term Assets | - | 14.66 | 0.55 | 0.02 | 1.06 | Upgrade
|
| Total Assets | - | 1,120 | 1,128 | 1,166 | 402.89 | Upgrade
|
| Accounts Payable | - | 1.31 | 3.64 | 4.28 | 2.47 | Upgrade
|
| Accrued Expenses | - | 14.57 | 16.92 | 17.05 | 11.48 | Upgrade
|
| Current Portion of Leases | - | 0.29 | 0.76 | 1.37 | 1.33 | Upgrade
|
| Current Income Taxes Payable | - | - | - | 1.51 | 0.4 | Upgrade
|
| Current Unearned Revenue | - | 2.2 | 2.93 | 1.99 | 1.44 | Upgrade
|
| Other Current Liabilities | - | 1.24 | 0.75 | 0.68 | 0.53 | Upgrade
|
| Total Current Liabilities | - | 19.62 | 24.99 | 26.87 | 17.65 | Upgrade
|
| Long-Term Leases | - | 4 | 12.2 | 12.31 | 13.02 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | 0.91 | 5.45 | 5.67 | 2.59 | Upgrade
|
| Total Liabilities | - | 24.53 | 42.63 | 44.86 | 33.26 | Upgrade
|
| Common Stock | - | 108.22 | 108.22 | 108.22 | 81.16 | Upgrade
|
| Additional Paid-In Capital | - | 878.09 | 878.09 | 871.49 | 113.62 | Upgrade
|
| Retained Earnings | - | 109.19 | 99.53 | 141.92 | 174.84 | Upgrade
|
| Total Common Equity | 1,125 | 1,096 | 1,086 | 1,122 | 369.63 | Upgrade
|
| Shareholders' Equity | 1,125 | 1,096 | 1,086 | 1,122 | 369.63 | Upgrade
|
| Total Liabilities & Equity | - | 1,120 | 1,128 | 1,166 | 402.89 | Upgrade
|
| Total Debt | 3.96 | 4.3 | 12.96 | 13.68 | 14.35 | Upgrade
|
| Net Cash (Debt) | 782.28 | 828.28 | 860.55 | 919.66 | 166.68 | Upgrade
|
| Net Cash Growth | -5.55% | -3.75% | -6.43% | 451.75% | 40.97% | Upgrade
|
| Net Cash Per Share | 7.26 | 7.67 | 7.99 | 9.02 | 2.05 | Upgrade
|
| Filing Date Shares Outstanding | 108.22 | 108.22 | 108.22 | 108.22 | 81.16 | Upgrade
|
| Total Common Shares Outstanding | 108.22 | 108.22 | 108.22 | 108.22 | 81.16 | Upgrade
|
| Working Capital | - | 896.74 | 923.94 | 970.18 | 230.29 | Upgrade
|
| Book Value Per Share | 10.40 | 10.12 | 10.03 | 10.36 | 4.55 | Upgrade
|
| Tangible Book Value | 1,102 | 1,072 | 1,062 | 1,097 | 345.66 | Upgrade
|
| Tangible Book Value Per Share | 10.19 | 9.91 | 9.81 | 10.14 | 4.26 | Upgrade
|
| Buildings | - | 121.51 | 64.9 | 60.97 | 58.87 | Upgrade
|
| Machinery | - | 71.64 | 67.04 | 62.65 | 55.95 | Upgrade
|
| Construction In Progress | - | 41.84 | 54.6 | 43.14 | 29.52 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.